Author Correction: PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.

Song, Chao; Chen, Tianwei; He, Lan; Ma, Ning; Li, Jian-Ang; Rong, Ye-Fei; Fang, Yuan; Liu, Mengmeng; Xie, Dong; Lou, Wenhui

Song, Chao; Chen, Tianwei; He, Lan; Ma, Ning; Li, Jian-Ang; Rong, Ye-Fei; Fang, Yuan; Liu, Mengmeng; Xie, Dong; Lou, Wenhui.

Afiliación

Song C; Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Chen T; Laboratory of Molecular Oncology, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Rd., Shanghai, 200031, China.
He L; University of the Chinese Academy of Sciences, Shanghai, 200031, China.
Ma N; School of Life Science and Technology, Shanghai Tech University, Shanghai, 201210, China.
Li JA; Laboratory of Molecular Oncology, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Rd., Shanghai, 200031, China.
Rong YF; University of the Chinese Academy of Sciences, Shanghai, 200031, China.
Fang Y; Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Liu M; Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Xie D; Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Lou W; Department of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai, 20032, China.

Cell Oncol (Dordr) ; 43(1): 63-64, 2020 02.

Article en En | MEDLINE | ID: mdl-31792888

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cell Oncol (Dordr) Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google